Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from EBOS Group Limited ( (AU:EBO) ) is now available.
EBOS Group Limited has disclosed a recent transaction involving the acquisition of ordinary shares by Director Elizabeth Coutts. The transaction, part of a retail offer, resulted in Coutts increasing her holdings from 35,748 to 37,112 shares, with the shares registered under Como Nominees Limited. This acquisition reflects ongoing investment and confidence in the company’s market position, potentially impacting stakeholder perceptions positively.
The most recent analyst rating on (AU:EBO) stock is a Buy with a A$39.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited operates in the healthcare and animal care industries, providing a wide range of products and services. The company focuses on the distribution and wholesaling of healthcare, medical, and pharmaceutical products, as well as animal care products, serving markets in Australia and New Zealand.
Average Trading Volume: 63,652
Technical Sentiment Signal: Buy
Current Market Cap: A$7.26B
See more insights into EBO stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue